ESMO Clinical Practice Guidelines: Haematological Malignancies
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
Latest enhanced and revised set of guidelines
ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Waldenstrom's macroglobulinaemia, Chronic myeloid leukaemia, Newly diagnosed and relapsed mantle cell lymphoma, Multiple myeloma, Newly diagnosed and relapsed follicular lymphoma, Extranodal diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma, acute lymphoblastic leukaemia, Peripheral T-cell lymphomas, Diffuse large B cell lymphoma, Chronic lymphocytic leukaemia, Hairy cell leukaemia, Philadelphia chromosome-negative chronic myeloproliferative neoplasms, Myelodysplastic syndromes, Hodgkin lymphoma, Primary cutaneous lymphomas, Acute myeloblastic leukaemia in adult patients, Gastric marginal zone lymphoma of MALT type.
They include information on incidence, diagnosis, staging and risk assessment, treatment, response evaluation and follow-up.
Plasma Cell Dyscrasias , Rare Cancers
Waldenstrom’s Macroglobulinemia: ESMO Clinical Practice Guidelines
Published in 2018 - Ann Oncol (2018) 29 (Suppl 4): iv41-iv51
Authors: E. Kastritis, V. Leblond, M.A. Dimopoulos, E. Kimby, P. Staber, M.J. Kersten, A. Tedeschi & C. Buske, on behalf of the ESMO Guidelines Committee
Haematologic Malignancies
ESMO Consensus Conference on Malignant Lymphoma: Management of ‘ultra-high-risk’ Patients
Published in 2018 – Ann Oncol (2018); 29: 1687–1700
Authors: M. Hutchings, M. Ladetto, C. Buske, P. de Nully Brown, A.J.M. Ferreri, M. Pfreundschuh, N. Schmitz, A. Sureda Balari, G. van Imhoff, J. Walewski & the ESMO Lymphoma Consensus Conference Panel Members
Lymphomas , Rare Cancers
Primary Cutaneous Lymphomas: ESMO Clinical Practice Guidelines
Published in 2018 – Ann Oncol (2018) 29 (Suppl 4): iv30-iv40
Authors: R. Willemze, E. Hodak, P. L. Zinzani, L. Specht & M. Ladetto, on behalf of the ESMO Guidelines Committee
Haematologic Malignancies , Lymphomas , Rare Cancers
Hodgkin Lymphoma: ESMO Clinical Practice Guidelines
Published in 2018 – Ann Oncol (2018) 29 (Suppl 4): iv19-iv29
Authors: D. A. Eichenauer, B. M. P. Aleman, M. André, M. Federico, M. Hutchings, T. Illidge, A. Engert & M. Ladetto, on behalf of the ESMO Guidelines Committee
Lymphomas
ESMO Consensus Conference on Malignant Lymphoma: General Perspectives and Recommendations for the Clinical Management of the Elderly Patient with Malignant Lymphoma
Published in 2017 – Ann Oncol 2017; 28: 2633–2651.
Authors: C. Buske, M. Hutchings, M. Ladetto, V. Goede, U. Mey, P. Soubeyran, M. Spina, R. Stauder, M. Trneny, U. Wedding, P. Fields & The ESMO Lymphoma Consensus Conference Panel Members
Leukaemia , Rare Cancers
Chronic Myeloid Leukaemia: ESMO Clinical Practice Guidelines
Published in 2017– Ann Oncol (2017) 28 (suppl 4): iv41–iv51
Authors: A. Hochhaus, S. Saussele, G. Rosti, F.-X. Mahon, J. J. W. M. Janssen, H. Hjorth-Hansen, J. Richter and C. Buske
Lymphomas
Newly Diagnosed and Relapsed Mantle Cell Lymphoma: ESMO Clinical Practice Guidelines
Published in 2017 – Ann Oncol (2017) 28 (suppl 4): iv62–iv71
Authors: M. Dreyling, E. Campo, O. Hermine, M. Jerkeman, S. Le Gouill, S. Rule, O. Shpilberg, J. Walewski and M. Ladetto
Plasma Cell Dyscrasias
Multiple Myeloma: ESMO Clinical Practice Guidelines
Published in 2017 – Ann Oncol (2017) 28 (suppl 4): iv52–iv61.
Authors: P. Moreau, J. San Miguel, P. Sonneveld, M. V. Mateos, E. Zamagni, H. Avet-Loiseau, R. Hajek, M. A. Dimopoulos, H. Ludwig, H. Einsele, S. Zweegman, T. Facon, M. Cavo, E. Terpos, H. Goldschmidt, M. Attal & C. Buske
Lymphomas
ESMO Consensus Conference on Malignant Lymphoma: General Perspectives and Recommendations for Prognostic Tools in Mature B-cell Lymphomas and Chronic Lymphocytic Leukaemia
Published in 2016 – Ann Oncol 2016; 00: 1–12, 2016
Authors: M. Ladetto, C. Buske, M. Hutchings, M. Dreyling, G. Gaidano, S. Le Gouill, S. Luminari, C. Pott, A. Zamò, E. Zucca and the ESMO Lymphoma Consensus Conference Panel Members
Lymphomas
Newly Diagnosed and Relapsed Follicular Lymphoma: ESMO Clinical Practice Guidelines
Published in 2016 – Ann Oncol (2016) 27 (suppl 5): v83-v90
Authors: M. Dreyling, M. Ghielmini, S. Rule, G. Salles, U. Vitolo & M. Ladetto
Lymphomas , Rare Cancers
Extranodal Diffuse Large B-Cell Lymphoma and Primary Mediastinal B-Cell Lymphoma: ESMO Clinical Practice Guidelines
Published in 2016 – Ann Oncol (2016) 27 (suppl 5): v91-v102
Authors: U. Vitolo, J. F. Seymour, M. Martelli, G. Illerhaus, T. Illidge, E. Zucca, E. Campo and M. Ladetto
Leukaemia , Rare Cancers
Acute Lymphoblastic Leukaemia in Adult Patients: ESMO Clinical Practice Guidelines
Published in 2016 – Ann Oncol (2016) 27 (suppl 5): v69-v82
Authors: D. Hoelzer, R. Bassan, H. Dombret, A. Fielding, J. M. Ribera and C. Buske
Lymphomas , Rare Cancers
Peripheral T-Cell Lymphomas: ESMO Clinical Practice Guidelines
Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v108-v115.
Authors: F. d'Amore, P. Gaulard, L. Trümper, P. Corradini, W.-S. Kim, L. Specht, M. Bjerregaard Pedersen, M. Ladetto
Lymphomas
Diffuse Large B-Cell Lymphoma: ESMO Clinical Practice Guidelines
Published in 2015 – Ann Oncol (2015) 26 (suppl 5): v116-v125.
Authors: H. Tilly, M. Gomes da Silva, U. Vitolo, A. Jack, M. Meignan, A. Lopez-Guillermo, J. Walewski, M. André, P. W. Johnson, M. Pfreundschuh, M. Ladetto
Leukaemia , Lymphomas
ESMO Consensus Conference: Diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
Published in 2013 - Ann Oncol (2013) 24 (3): 561-576.
Authors: M. Ghielmini, U. Vitolo, E. Kimby, S. Montoto, J. Walewski, M. Pfreundschuh, M. Federico, P. Hoskin, C. McNamara, F. Caligaris-Cappio, S. Stilgenbauer, R. Marcus, M. Trneny, P. Dreger, E. Montserrat, M. Dreyling